首页> 外文期刊>Asia-Pacific Biotech News >WuXi PharmaTech launches representative office in Israel, forms strategic collaboration with Pontifax
【24h】

WuXi PharmaTech launches representative office in Israel, forms strategic collaboration with Pontifax

机译:药明康德在以色列设立代表处,与庞蒂法克斯建立战略合作关系

获取原文
获取原文并翻译 | 示例
           

摘要

WuXi PharmaTech, a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, has established a representative office inthe Tel Aviv area of Israel.The new office will promote WuXi's broad platform of integrated REtD services to local customers. It will also collaborate with Pontifax, a leading healthcare-dedicated venture capital firm based in Israel, to invest in promising technologies in Israel,particularly those that can potentially advance WuXi's capabilities.
机译:药明康德(WuXi PharmaTech)是一家领先的开放式研发能力和技术平台公司,为制药,生物技术和医疗器械行业提供服务,并在中国和美国开展业务,已在以色列特拉维夫地区设立了代表处。向本地客户推广无锡整合REtD服务的广泛平台。它还将与总部位于以色列的领先的专注于医疗保健的风险投资公司Pontifax合作,在以色列投资有前途的技术,特别是那些有可能提高药明康德能力的技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号